IL-17 Receptor C Signaling Controls CD4+ TH17 Immune Responses and Tissue Injury in Immune-Mediated Kidney Diseases
December 2021 | New Publication
A recent study by Tilman Schmidt and colleagues in the Journal of the American Society of Nephrology indicates that IL-17 receptor C signaling has a previously unrecognized function in the regulation of CD4+ TH17 cells and in the control of organ-specific autoimmunity and might provide new insights into the development of more efficient anti-TH17 treatment strategies.
For further information visit:
IL-17 Receptor C Signaling Controls CD4+ TH17 Immune Responses and Tissue Injury in Immune-Mediated Kidney Diseases | American Society of Nephrology (asnjournals.org)
Martinistraße 52
Campus Research II N25
20246 Hamburg Germany
Categories
Services
